Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 102,975 m |
| EPS, EUR | - |
| P/B ratio | 1.4 |
| P/E ratio | 12.2 |
| Dividend yield | 3.26% |
| Revenue, EUR | 41,081 m |
| Net income, EUR | 5,496 m |
| Profit margin | 13.38% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.05% | Equity United States Health Care Biotech | 45 |
| YTD | -1.21% |
| 1 month | -1.45% |
| 3 months | -0.97% |
| 6 months | -1.68% |
| 1 year | -13.89% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | -6.19% |
| 2025 | -11.35% |
| 2024 | +4.01% |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 26.25% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.53 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -29.45% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -29.45% |